Insider Selling: Rocket Lab (NASDAQ:RKLB) Director Sells 96,000 Shares of Stock

Rocket Lab Corporation (NASDAQ:RKLB) Director Merline Saintil sold 96,000 shares of the stock in a transaction that occurred on Tuesday, January 13th. The stock was sold at an average price of $86.58, for a total transaction of $8,311,680.00. Following the sale, the director owned 292,529 shares in the company, valued at $25,327,160.82. This represents a 24.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Merline Saintil also recently made the following trade(s):

• On Friday, December 19th, Merline Saintil sold 5,000 shares of Rocket Lab stock. The shares were sold at an average price of $65.00, for a total value of $325,000.00.
• On Wednesday, December 17th, Merline Saintil sold 5,000 shares of Rocket Lab stock. The stock was sold at an average price of $54.46, for a total value of $272,300.00.
• On Friday, December 12th, Merline Saintil sold 15,000 shares of Rocket Lab stock. The shares were sold at an average price of $65.00, for a total value of $975,000.00.
• On Thursday, December 4th, Merline Saintil sold 10,000 shares of Rocket Lab stock. The shares were sold at an average price of $48.00, for a total value of $480,000.00.

Rocket Lab Price Performance

Shares of RKLB stock traded down $1.04 on Thursday, reaching $90.76. The company had a trading volume of 24,654,674 shares, compared to its average volume of 28,782,193. The business’s 50-day moving average is $59.82 and its 200 day moving average is $53.41. Rocket Lab Corporation has a one year low of $14.71 and a one year high of $92.46. The company has a quick ratio of 2.83, a current ratio of 3.18 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $48.48 billion, a PE ratio of -238.84 and a beta of 2.16.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings data on Monday, November 10th. The rocket manufacturer reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. The business had revenue of $155.08 million during the quarter, compared to analysts’ expectations of $152.45 million. Rocket Lab had a negative net margin of 35.64% and a negative return on equity of 27.26%. The firm’s quarterly revenue was up 48.0% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.10) EPS. Equities research analysts forecast that Rocket Lab Corporation will post -0.38 EPS for the current fiscal year.

Key Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Large U.S. defense win and backlog boost — an $816M SDA contract and other wins doubled Rocket Lab’s backlog, underpinning bullish views on near-term revenue and helping push the stock to record highs. Rocket Lab (RKLB) Stock: Defense Contract Win Drives Shares to All-Time High
• Positive Sentiment: Street bullish thesis on 2026 revenue and defense-led growth — analysis projects ~\$900M revenue in 2026 as Space Systems backlog converts, sustained 30%+ growth from defense programs, and Electron supporting execution credibility. This underpins upside expectations if execution continues. Rocket Lab Enters A Different League
• Positive Sentiment: Analyst upgrades and bullish coverage — firms like Cantor Fitzgerald and a Zacks upgrade to “strong-buy” have reinforced the narrative that RKLB is a leading SpaceX alternative with upside tied to Neutron commercialization and defense contracts. Rocket Lab: Premier Alternative To SpaceX in 2026
• Neutral Sentiment: Market commentary and longer-term cautious views — several feature pieces (Fool, MarketBeat) lay out catalysts (Neutron, launch cadence, defense revenue) but note valuation and execution risks; these provide context rather than immediate catalyst. Is Rocket Lab Stock a Buy After Its Massive Run?
• Neutral Sentiment: Options and institutional flow interest — coverage notes heavy options activity and institutional buying that has amplified the move; these flows can increase volatility but aren’t a fundamental change. Check Out What Whales Are Doing With RKLB
• Negative Sentiment: KeyBanc downgrade to Sector Weight — an influential analyst cut RKLB from Overweight to Sector Weight citing stretched sentiment/valuation, prompting intraday weakness. Analyst downgrades can trigger short-term selling even amid bullish fundamentals. Rocket Lab Stock Gets A Rare Downgrade—Here’s Why
• Negative Sentiment: Insider/director share sale — Rocket Lab director Merline Saintil sold 96,000 shares (~\$8.3M at ~$86.58), reducing her stake by ~24.7%; large insider sales can be perceived negatively even when they’re routine or for diversification/liquidity reasons. Insider Sale: Merline Saintil
• Negative Sentiment: Valuation and “Neutron euphoria” concerns — some analysts contend the rally has priced in best-case outcomes for Neutron and could leave the stock vulnerable to a meaningful pullback if milestones slip. Neutron Euphoria Has Pushed RKLB Into Sell Territory

Analysts Set New Price Targets

RKLB has been the subject of several recent research reports. Morgan Stanley decreased their price target on shares of Rocket Lab from $68.00 to $67.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 12th. Wall Street Zen raised Rocket Lab from a “sell” rating to a “hold” rating in a research note on Saturday, January 3rd. Needham & Company LLC increased their target price on shares of Rocket Lab from $63.00 to $90.00 and gave the company a “buy” rating in a research report on Tuesday, December 23rd. Baird R W upgraded shares of Rocket Lab to a “strong-buy” rating in a research report on Thursday, October 16th. Finally, Citigroup reiterated a “market perform” rating on shares of Rocket Lab in a research report on Wednesday, November 12th. Three analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $61.25.

Institutional Investors Weigh In On Rocket Lab

Hedge funds have recently added to or reduced their stakes in the company. Lodestone Wealth Management LLC acquired a new position in shares of Rocket Lab during the fourth quarter worth approximately $195,000. Cherry Creek Investment Advisors Inc. raised its holdings in Rocket Lab by 50.9% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 11,318 shares of the rocket manufacturer’s stock worth $790,000 after buying an additional 3,817 shares during the last quarter. Nikulski Financial Inc. acquired a new position in Rocket Lab during the fourth quarter worth $575,000. Fifth Third Wealth Advisors LLC bought a new position in shares of Rocket Lab in the fourth quarter valued at $249,000. Finally, Silver Oak Securities Incorporated grew its holdings in shares of Rocket Lab by 26.7% during the fourth quarter. Silver Oak Securities Incorporated now owns 3,828 shares of the rocket manufacturer’s stock valued at $270,000 after buying an additional 807 shares during the last quarter. Institutional investors and hedge funds own 71.78% of the company’s stock.

Rocket Lab Company Profile

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.